Cancer drug maker wants 4000% Spanish price hike
Price-fixing negotiaions between the manufacturer and Spain's government are said to be in critical condition. Photo: JEAN-PIERRE MULLER/AFP
12 February 2014
Two MBA graduates from EMLYON Business School explain how their studies helped them to land their dream jobs working for international organisations.